Treatment of HCC cells with 5-Aza-2’-deoxycytidine (5-aza-dC, also known as decitabine), a pyrimidine analogue that incorporates into DNA and inhibits DNMTs, led to increased MICB surface expression, which enhanced susceptibility to NK cell-mediated killing (133). Here, MICB is linked to hepatocellular carcinoma.